The future is here: an overview of technology in diabetes

Given the recent and ongoing advances in diabetes technology, we commissioned a series of reviews on this topic. This issue includes nine comprehensive reviews spanning the use of diabetes technology in different diabetes populations (type 1 diabetes, type 2 diabetes, older adults, children and pregnant women [Boughton and Hovorka, https://doi.org/10.1007/s00125-024-06165-w; Wilmot and colleagues, https://doi.org/10.1007/s00125-024-06203-7; Breton and colleagues, https://doi.org/10.1007/s00125-024-06218-0; Maltese et al, https://doi.org/10.1007/s00125-024-06240-2; Murphy and colleagues, https://doi.org/10.1007/s00125-024-06216-2]) to the application of these devices in individuals with diabetes and comorbidities, such as cystic fibrosis-related diabetes (Putman and colleagues, https://doi.org/10.1007/s00125-024-06223-3) and chronic kidney disease (Galindo et al, https://doi.org/10.1007/s00125-024-06244-y). In addition, we present reviews on the use of diabetes technology in unique contexts, such as in hospitalised individuals (Thabit and Schofield, https://doi.org/10.1007/s00125-024-06206-4) or during exercise (Perkins et al, https://doi.org/10.1007/s00125-024-06229-x). Most importantly, we wanted to ensure that the voices of individuals living with diabetes were heard. We have been fortunate enough to work with a group of ten inspiring individuals living with diabetes from around the globe who have generously shared their direct experiences of diabetes technology (Scibilia et al, https://doi.org/10.1007/s00125-024-06230-4). This review set is accompanied by an editorial by Kar and colleagues (https://doi.org/10.1007/s00125-024-06235-z).

All News